Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure. A Pilot Study.

Antoni Bayés-Genís, Jaume Barallat, Domingo Pascual, Julio Nuñez, Gema Miñana, Jesús Sánchez-Mas, Amparo Galan, Juan Sanchis, Elisabet Zamora, María Teresa Pérez-Martínez, Josep Lupón

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

Abstract

© 2015 American College of Cardiology Foundation. Objectives: This study sought to examine the prognostic value of the soluble form of neprilysin (sNEP) in acute heart failure (AHF) and sNEP kinetics during hospital admission. Background: sNEP was recently identified in chronic heart failure (HF) and was associated with cardiovascular outcomes. Methods: A total of 350 patients (53% women, mean 72.6 ± 10.7 years of age) were included in the study. Primary endpoints were composites of cardiovascular death or HF hospitalizations at short-term (2 months) and long-term (mean: 1.8 ± 1.2 years) follow-up. sNEP was measured using an ad hoc-modified enzyme-linked immunosorbent assay, and its prognostic value was assessed using Cox regression analyses. In a subgroup of patients, sNEP was measured both at admission and at discharge (n = 92). Results: Median admission sNEP concentrations were 0.67 ng/ml (Q1 to Q3: 0.37 to 1.29), and sNEP was significantly associated, in age-adjusted Cox regression analyses, with the composite endpoint at short-term (hazard ratio [HR]: 1.29; 95% confidence interval [CI]: 1.04 to 1.61; p = 0.02) and long-term (HR: 1.23; 95% CI: 1.01 to 1.05; p = 0.003) follow-up. In multivariate Cox analyses that included clinical variables and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) concentration, sNEP concentration at admission showed a clear trend toward significance for the composite endpoint at 2 months (HR: 1.22; 95% CI: 0.97 to 1.53; p = 0.09) and remained significant at the end of follow-up (HR: 1.21; 95% CI: 1.04 to 1.40; p = 0.01). At discharge, sNEP levels decreased from 0.70 to 0.52 ng/ml (p = 0.06). Conclusions: Admission sNEP concentration was associated with short- and long-term outcomes in AHF, and dynamic sNEP concentrations were observed during hospital admission. These preliminary data may be hypothesis-generating for the use of NEP inhibitors in AHF.
Original languageEnglish
Pages (from-to)641-644
JournalJACC: Heart Failure
Volume3
Issue number8
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • Acute heart failure
  • Neprilysin
  • Prognosis

Fingerprint Dive into the research topics of 'Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure. A Pilot Study.'. Together they form a unique fingerprint.

Cite this